Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

Reference Safety Information

Better understand basic aspects of the EU Regulation and Guidance that govern the content, placement, use, and management of the Reference Safety Information for assessing expectedness and causality to determine reportability of individual clinical trial cases.

Overview

The implementation of the EU requirements for the use of Reference Safety Information (RSI) in determining expectedness of “suspected” serious adverse reactions (SARs) from clinical trials continues to be challenging. This course will focus, at a high level, on the basic aspects of the EU Regulation and EU Guidance (including Q&A Documents) that govern the content, placement, use, and management of the Reference Safety Information and compare/contrast with the US FDA approach to assessing expectedness and causality to determine reportability of individual clinical trial cases. Practical aspects of implementing the regulations and guidance, criteria for updating the RSI, UK MHRA approach following Brexit and a review of acceptable and non-acceptable examples of the RSI will also be reviewed.

This on-demand course takes an average of 2 hours to complete. Learners have access to the course for one year from the date of purchase

Featured topics

    • EU RSI requirements
    • IND reporting requirements and contrast with EU reporting requirements
    • Updating the RSI
    • MHRA and the RSI
    • Issues with RSI submissions
    • Managing IB submissions
    • Examples

Who should attend?

  • This course is designed for professionals involved in:

    • Clinical safety/pharmacovigilance
    • Clinical research
    • Document management
    • Pharmacology
    • Regulatory affairs
    • Submissions
    • Validation
      • Learning objectives

        • At the conclusion of this course, participants should be able to:

          • Identify the requirements for the use and management of Reference Safety Information in clinical trials
          • Recognize how the requirements for RSI are enforced by regulatory agencies
          • Determine compliant RSI processes and documentation

          Have an account?

          Be informed and stay engaged.

          Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.